期刊文献+

孟鲁司特治疗咳嗽变异性哮喘80例 被引量:20

Analysis on the effect of montelukast sodium for the treatment of 80 cases of cough variant asthma
原文传递
导出
摘要 目的:观察分析小儿咳嗽变异性哮喘(CVA)的效果。方法:选择2011年1月-10月在某院就诊的80例CVA患者,随机分为观察组和对照组,对照组用常规方法治疗,观察组在此基础上加用孟鲁司特钠。结果:观察组治疗总有效率为92.5%,对照组为72.5%,2组比较差异有统计学意义(P<0.05)。结论:白三烯受体拮抗剂孟鲁司特治疗CVA,服用方便,起效快,能明显提高有效率,改善肺功能,不良反应少,用于低龄儿童较为安全。 OBJECTIVE To observe an (CVA) in children. METHODS 80 cases servation group and control group). Rout vation group in addition. RESULTS The d analyze the effect of montelukast sodium for the treatment of cough variant asthma of patients of cough variant asthma from 2011.1 - 10) were divided into 2 groups (ob- ine therapy was given to control group, while montelukast sodium was given to obser- total effective rate was 92. 5% in observation group and 72. 5% in control group, the difference between the two groups was statistically significant (〈0. 05). CONCLUSION The leukotriene receptor antagonist montelukast can be used conveniently for the treatment of CVA and the onset of its effect is rapid, it can obviously increase the efficient rate, improve the lung: functions and brink only fewer side effects, more securely in treating: underage children.
作者 徐佳莉
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第14期1137-1139,共3页 Chinese Journal of Hospital Pharmacy
关键词 孟鲁司特 咳嗽变异性哮喘 效果 小儿 montelukast sodium cough variant asthma effect underage children
  • 相关文献

参考文献6

二级参考文献46

  • 1Fregonese L, Silvestri M, Sabatini F, et al. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a Cys-LTI receptor mediated mechanism. Clin Exp Allergy, 2002, 32: 745-750.
  • 2Braccioni F, Dorman SC, O′ byrne PM, et al. The effect of cysteinyl leukotrenes on growth of eosinophil proge from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol, 2002, 110:96-101.
  • 3Murray J, Ward c, O′ Flaberty JT, et al. Role of leukotrenes in the regulation of human granulecyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis. Br J Pharmacol, 2003, 139:388-398.
  • 4Henderson WR Jr, Tang LO, Chu SJ, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med, 2002, 165:108-116.
  • 5Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum ECP, sIL-2R, IL-4, and sICAM-1 in children with asthma. J Allergy Clin Immunol, 2002,109: 257-263.
  • 6Stelmach I, Grzelewski T, Stelmach W, et al. Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children. Pol Merkuriusz Lek, 2002,12:208-213.
  • 7Strauch E, Moske O, Thoma S, et al. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Pediatr Res, 2003, 54:198-203.
  • 8Diamant Z, Grootendorst DC, Veselic-Charvat M, et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy, 1999, 29:42-51.
  • 9Wu AY, Chik SC, Chan AW, et al. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma. Clin Exp Allergy, 2003, 33:359-366.
  • 10Finsnes F, Lyberg T, Christensen G, et al. Leukotriene antagonism reduces the generation of endothelin-1 and IFN-γand inhibits eosinophilic airway inflammation. Respir Med, 2002,96: 901-906.

共引文献3046

同被引文献216

引证文献20

二级引证文献260

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部